<b>Effect of the nicotine on actived phagocytes</b> - doi: 10.4025/actascihealthsci.v35i1.11129

  • Andreza Urba de Quadros Universidade Estadual do Centro-Oeste
  • Loriangela Marceli Dalposso Universidade Estadual do Centro-Oeste
  • Thaysa Ksiaskiewcz Karam Universidade Estadual do Centro-Oeste
  • Rubiana Mara Mainardes Universidade Estadual do Centro-Oeste
  • Najeh Maissar Khalil Universidade Estadual do Centro-Oeste
Keywords: viability, zymosan, phorbol myristate acetate, reactive oxygen species

Abstract

Smokers show increased rates of polymorphonuclear leukocytes (PMNL), including in pulmonary tissue, resulting increased levels of proteolytic enzymes and reactive oxygen species, which have a destructive effect on the cellular matrix and contribute to the progression of pulmonary disease, in addition to promoting the onset of microbial infections which cause phagocytic cells to be in a state of frequent activation (phagocytosis). This work evaluated the influence of nicotine (NIC) on the viability of PMNL and macrophages (activated or not), by stimuli zymosan and phorbol myristate acetate. The results indicated that NIC led to increased viability of PMNL and activated macrophages compared to these cells activated without NIC, measured ex vivo by trypan blue exclusion test. This effect was significantly higher on PMNL than on macrophages. This reduction in cytotoxicity favors cell survival, and may exacerbate its deleterious effect, especially in the active state, due to increased production of reactive oxygen species.

 

Downloads

Download data is not yet available.

Author Biography

Najeh Maissar Khalil, Universidade Estadual do Centro-Oeste
Possui experiência na área de produtos naturais, processos oxidativos e nanotecnologia farmacêutica. Currículo Lattes
Published
2012-10-31
How to Cite
Quadros, A. U. de, Dalposso, L. M., Karam, T. K., Mainardes, R. M., & Khalil, N. M. (2012). <b>Effect of the nicotine on actived phagocytes</b&gt; - doi: 10.4025/actascihealthsci.v35i1.11129. Acta Scientiarum. Health Sciences, 35(1), 105-109. https://doi.org/10.4025/actascihealthsci.v35i1.11129
Section
Pharmacy

0.3
2019CiteScore
 
 
8th percentile
Powered by  Scopus

 

 

0.3
2019CiteScore
 
 
8th percentile
Powered by  Scopus